Clinical Review
Effectiveness of Rosiglitazone and Pioglitazone to Reduce Hemoglobin A1c Levels in Veteran Patients With Type 2 Diabetes
Fed Pract. 2010 October;27(10):22
Author and Disclosure Information
Jessica Galvan, PharmD, PhC; Catherine J. Cone, PharmD, BCPS; and Glen H. Murata, MD
Dr. Galvan is a primary care specialist in the Pharmacy Department at the New Mexico VA Health Care System (NMVAHCS) in Albuquerque. Dr. Cone is an assistant professor in the Department of Pharmacy Practice at the University of New Mexico College of Pharmacy in Albuquerque. Dr. Murata is a staff physician in the Internal Medicine Department and the director of the Outcomes Research Program at the NMVAHCS and a professor of medicine at the University of New Mexico School of Medicine in Albuquerque.
Reported drug efficacy can vary drastically when patients are treated in a real-world environment. These authors studied whether the treatment results from these medications are worth their safety risks.